Mather Group LLC. Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Posted by Defense World Staff on Jun 20th, 2023

Mather Group LLC. lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 12.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,113 shares of the medical equipment provider’s stock after selling 165 shares during the period. Mather Group LLC.’s holdings in Intuitive Surgical were worth $295,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of ISRG. MADDEN SECURITIES Corp bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Paragon Wealth Strategies LLC bought a new position in Intuitive Surgical in the 4th quarter worth $27,000. Evermay Wealth Management LLC lifted its position in shares of Intuitive Surgical by 103.4% in the 4th quarter. Evermay Wealth Management LLC now owns 118 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 60 shares during the period. MinichMacGregor Wealth Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $35,000. Finally, Capital Directions Investment Advisors LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at about $37,000. Institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Evercore ISI lifted their price objective on Intuitive Surgical from $240.00 to $270.00 and gave the company an “inline” rating in a research report on Wednesday, April 19th. Bank of America increased their price objective on Intuitive Surgical from $300.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, April 19th. Citigroup boosted their target price on shares of Intuitive Surgical from $305.00 to $317.00 and gave the company a “buy” rating in a report on Wednesday, April 19th. Mizuho increased their price target on shares of Intuitive Surgical from $240.00 to $250.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 18th. Finally, StockNews.com initiated coverage on shares of Intuitive Surgical in a research note on Thursday, May 18th. They set a “buy” rating on the stock. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $303.35.

Insider Transactions at Intuitive Surgical

In other news, Director Mark J. Rubash sold 1,683 shares of the company’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $297.92, for a total value of $501,399.36. Following the completion of the sale, the director now directly owns 15,000 shares in the company, valued at approximately $4,468,800. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, VP Fredrik Widman sold 630 shares of Intuitive Surgical stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $297.87, for a total transaction of $187,658.10. Following the transaction, the vice president now directly owns 2,233 shares of the company’s stock, valued at approximately $665,143.71. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Mark J. Rubash sold 1,683 shares of the stock in a transaction that occurred on Friday, April 21st. The stock was sold at an average price of $297.92, for a total transaction of $501,399.36. Following the completion of the sale, the director now directly owns 15,000 shares of the company’s stock, valued at $4,468,800. The disclosure for this sale can be found here. Insiders have sold 75,283 shares of company stock worth $22,923,158 in the last 90 days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $329.36 on Tuesday. Intuitive Surgical, Inc. has a one year low of $180.07 and a one year high of $333.14. The stock has a fifty day moving average of $302.76 and a 200 day moving average of $269.99. The stock has a market cap of $115.41 billion, a PE ratio of 89.99, a price-to-earnings-growth ratio of 5.89 and a beta of 1.31.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its quarterly earnings results on Tuesday, April 18th. The medical equipment provider reported $1.23 EPS for the quarter, beating the consensus estimate of $1.20 by $0.03. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.59 billion. Intuitive Surgical had a net margin of 20.40% and a return on equity of 11.39%. The business’s revenue for the quarter was up 14.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.00 EPS. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 4.3 EPS for the current fiscal year.

Intuitive Surgical Profile

(Get Rating)

Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.